| Sotagliflozin Bioequivalence Study (NCT03211195) | Sanofi | 2017-06-29 |
| Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR) (NCT02578511) | Ehab L Atallah | 2017-06-29 |
| NLG802 Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors (NCT03164603) | NewLink Genetics Corporation | 2017-06-29 |
| A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies (NCT03205046) | Acerta Pharma BV | 2017-06-29 |
| Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT02947386) | Roswell Park Cancer Institute | 2017-06-29 |
| This Study Tests in Healthy Korean Women Which Effects BI 409306 and a Birth-control Pill Have on Each Other (NCT03193307) | Boehringer Ingelheim | 2017-06-29 |
| Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma (NCT03024437) | Roberto Pili | 2017-06-29 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect Cohort (NCT03682484) | Astellas Pharma Global Development, Inc. | 2017-06-29 |
| Pharmacokinetics of GLPG2737 in Male Subjects With Cystic Fibrosis (NCT03450720) | Lakefront Biotherapeutics NV | 2017-06-28 |
| To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants (NCT03224260) | Bristol-Myers Squibb | 2017-06-28 |
| A Low ChloridE hyperTonic Solution for Brain Edema (NCT03204955) | Emory University | 2017-06-28 |
| Ruboxistaurin in New York Heart Failure Classification III-IV Patients (NCT02769611) | University of Tennessee | 2017-06-28 |
| A Study of EPEG in Beta Thalassemia Patients (NCT02950857) | Prolong Pharmaceuticals | 2017-06-28 |
| Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects (NCT03141658) | Taisho Pharmaceutical R&D Inc. | 2017-06-28 |
| A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility (NCT03065959) | Astellas Pharma Global Development, Inc. | 2017-06-28 |
| Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver (NCT03005002) | City of Hope Medical Center | 2017-06-28 |
| A Study to Test the Effects of BMS-986036 on the Body in Healthy Japanese and Non-Japanese Subjects (NCT03198182) | Bristol-Myers Squibb | 2017-06-28 |
| Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN (NCT03203369) | Cellectis S.A. | 2017-06-28 |
| Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors (NCT03150810) | BeiGene | 2017-06-28 |
| A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV (NCT03213405) | Pontificia Universidad Catolica de Chile | 2017-06-27 |
| A Study of Baricitinib in Healthy Participants (NCT03212638) | Eli Lilly and Company | 2017-06-27 |
| A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants (NCT03173573) | Flatley Discovery Lab LLC | 2017-06-27 |
| Fluid Filled Lung Oxygenation Assistance Trial (NCT03041740) | Children's Hospital of Philadelphia | 2017-06-27 |
| Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART) (NCT03212989) | University of North Carolina, Chapel Hill | 2017-06-27 |
| Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma (NCT03278626) | NYU Langone Health | 2017-06-27 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Japanese Participants (NCT03080987) | Janssen Research & Development, LLC | 2017-06-27 |
| Safety of Intranodal ECI-006 in Melanoma Patients (NCT03394937) | eTheRNA immunotherapies | 2017-06-27 |
| A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell Malignancies (NCT03198650) | AstraZeneca | 2017-06-27 |
| A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes (NCT02624804) | Hackensack Meridian Health | 2017-06-27 |
| Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062) (NCT03099161) | Merck Sharp & Dohme LLC | 2017-06-27 |
| Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects (NCT03027960) | Yale University | 2017-06-27 |
| Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC (NCT03201146) | West China Hospital | 2017-06-27 |
| A Study of ONO-7475 in Patients With Acute Leukemias (NCT03176277) | Ono Pharmaceutical Co., Ltd. | 2017-06-26 |
| SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) (NCT03113643) | Dana-Farber Cancer Institute | 2017-06-26 |
| QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer (NCT03127098) | NantCell, Inc. | 2017-06-26 |
| Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer (NCT03162224) | MedImmune LLC | 2017-06-26 |
| Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers (NCT03056209) | Yungjin Pharm. Co., Ltd. | 2017-06-26 |
| Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT03064867) | Molly Gallogly | 2017-06-26 |
| A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001) (NCT03162536) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2017-06-26 |
| Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma (NCT03068351) | Hoffmann-La Roche | 2017-06-26 |
| CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL) (NCT03289455) | Autolus Limited | 2017-06-26 |
| Blood Brain Barrier Opening in Alzheimer' Disease (NCT03119961) | Assistance Publique - Hôpitaux de Paris | 2017-06-26 |
| A Single Ascending Dose Clinical Trial to Find the Maximum Tolerable Dose of HL237 in Healthy Male Subject (NCT03278470) | Hanlim Pharm. Co., Ltd. | 2017-06-26 |
| Improving Function,Welfare of Late-stage Cancer Subjects by ACC (NCT03057314) | Amorphical Ltd. | 2017-06-25 |
| A Pilot, Dose Escalating Study on VLX103 in Moderate Alcoholic Steatohepatitis (NCT03201159) | Gyongyi Szabo | 2017-06-25 |
| Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma (NCT03088176) | West Cancer Center | 2017-06-25 |
| Effects of Carbon Monoxide Breathing on Blood Vessel Function (NCT03067701) | Cedars-Sinai Medical Center | 2017-06-23 |
| Aripiprazole IM Depot for Chinese Patients With Schizophrenia (NCT03287505) | Otsuka Beijing Research Institute | 2017-06-23 |
| Testing the Safety and Efficacy of the Combination of the Antibody Pembrolizumab and Entinostat in Patients With Myelodysplastic Syndrome Who Are Not Responding to Hypomethylating Agents (NCT02936752) | National Cancer Institute (NCI) | 2017-06-23 |
| Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer (NCT03112590) | H. Lee Moffitt Cancer Center and Research Institute | 2017-06-23 |
| A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors (NCT03192943) | Bristol-Myers Squibb | 2017-06-23 |
| A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer (NCT03086369) | Eli Lilly and Company | 2017-06-22 |
| Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer (NCT03430479) | Kyoto Breast Cancer Research Network | 2017-06-22 |
| Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma (NCT03137199) | Marilyn Glassberg | 2017-06-22 |
| WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer (NCT03028766) | University of Birmingham | 2017-06-22 |
| Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC (NCT03428295) | Dose Safety Inc. | 2017-06-22 |
| A Study of Inclisiran in Participants With Renal Impairment Compared to Participants With Normal Renal Function (ORION-7) (NCT03159416) | The Medicines Company | 2017-06-22 |
| Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants (NCT03210909) | Bristol-Myers Squibb | 2017-06-22 |
| A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults (NCT03201211) | GlaxoSmithKline | 2017-06-22 |
| A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786 (NCT03236233) | Pulmocide Ltd | 2017-06-21 |
| Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients (NCT03256331) | Belx Bio-Pharmaceutical (Taiwan) Corporation | 2017-06-21 |
| Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies (NCT03056339) | M.D. Anderson Cancer Center | 2017-06-21 |
| A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT03091257) | Massachusetts General Hospital | 2017-06-21 |
| Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis (NCT03118492) | City of Hope Medical Center | 2017-06-21 |
| Study of the Safety of KSP Heptapeptide (KSP-910638G) (NCT03161418) | University of Michigan | 2017-06-21 |
| Safety and Pharmacokinetics of Cemiplimab Anti-programmed Death-ligand 1 (Anti-PD-1) and Other Agents in Japanese Adult Patients With Advanced Malignancies (NCT03233139) | Regeneron Pharmaceuticals | 2017-06-21 |
| VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease (NCT02898753) | Valerion Therapeutics, LLC | 2017-06-21 |
| Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma (NCT03208556) | Peking University | 2017-06-21 |
| Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma (NCT03116529) | University of Maryland, Baltimore | 2017-06-21 |
| A Phase I Trial of LY3143921 Hydrate in Solid Tumours (NCT03096054) | Cancer Research UK | 2017-06-21 |
| Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain (NCT03060031) | University of Colorado, Boulder | 2017-06-21 |
| Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea (NCT03079531) | Anne Chang | 2017-06-21 |
| Bioequivalence Study of Tenofovir Disoproxil Fumarate Tablets in Healthy Chinese Subjects (NCT07558967) | Haisco Pharmaceutical Group Co., Ltd. | 2017-06-20 |
| Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma (NCT03147885) | Barbara Ann Karmanos Cancer Institute | 2017-06-20 |
| Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone (NCT03116295) | Bial - Portela C S.A. | 2017-06-20 |
| Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female Subjects (NCT03183739) | Astellas Pharma Inc | 2017-06-20 |
| Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function (NCT03186495) | Novo Nordisk A/S | 2017-06-20 |
| Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma (NCT03178851) | Hoffmann-La Roche | 2017-06-20 |
| A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy (NCT03015623) | Sentien Biotechnologies, Inc. | 2017-06-20 |
| A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects (NCT03211143) | Chong Kun Dang Pharmaceutical | 2017-06-20 |
| A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer (NCT03212469) | Gustave Roussy, Cancer Campus, Grand Paris | 2017-06-20 |
| Study of the Pharmacokinetics and Safety of Trastuzumab Emtansine in Chinese Participants With Locally Advanced Inoperable or Metastatic HER2+ Breast Cancer (NCT03153163) | Hoffmann-La Roche | 2017-06-20 |
| Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study (NCT03120533) | University Hospital, Grenoble | 2017-06-20 |
| A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump (NCT03179332) | Adocia | 2017-06-20 |
| A Study to Evaluate the Effects of Food and Esomeprazole on the Pharmacokinetics of Crizotinib in a Coated Microsphere Formulation. (NCT03137134) | Pfizer | 2017-06-20 |
| A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal Block (NCT04494321) | Intech Biopharm Ltd. | 2017-06-19 |
| Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects (NCT03214874) | Sarfez Pharmaceuticals, Inc. | 2017-06-19 |
| ⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma (NCT03107663) | ImaginAb, Inc. | 2017-06-19 |
| Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT03190278) | Cellectis S.A. | 2017-06-19 |
| Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects (NCT03159442) | AstraZeneca | 2017-06-19 |
| A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer (NCT03131206) | Dana-Farber Cancer Institute | 2017-06-19 |
| Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine (NCT03284710) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-06-19 |
| Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy (NCT02925000) | Taiwan Liposome Company | 2017-06-19 |
| Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors (NCT03507998) | Curegenix Inc. | 2017-06-17 |
| Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing Enzymes (NCT03195946) | H. Lundbeck A/S | 2017-06-16 |
| A Study to Assess the Metabolism, Excretion, and Mass Balance of Radio-Labeled Plazomicin (NCT03177278) | Achaogen, Inc. | 2017-06-16 |
| Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer (NCT03262103) | Ashutosh Kumar Tewari | 2017-06-16 |
| A Study of Lasmiditan in Healthy Participants (NCT03182920) | Eli Lilly and Company | 2017-06-16 |
| Safety and Tolerability of SYNB1020-CP-001 (NCT03179878) | Synlogic | 2017-06-16 |
| Immunological Response to Intravesical BCG Therapy of Superficial Bladder Cancer by Prior Administration of RUTI® (NCT03191578) | Archivel Farma S.L. | 2017-06-16 |